
E137: Obexelimab in IgG4-RD (INDIGO)
Jun 29, 2026 - 15:36
Radio and PodcastLive Radio & PodcastsFetching episode details...
Radio and PodcastLive Radio & Podcasts
A new therapy for SLE! This one is a CD40-CD40L blocker, which has some nice new-things to inhibit. The study itself was a qualified success and the podcast got a bit more rant-y than it should have been, but hopefully y...
E138: Dapirolizumab for SLE (PHOENYCS-GO) is an episode from The Evidence Based Rheumatology Podcast by Michael Putman. A new therapy for SLE! This one is a CD40-CD40L blocker, which has some nice new-things to inhibit. The study itself was...
This episode belongs to The Evidence Based Rheumatology Podcast.
Use the player on this page to stream the episode online.
Published Jul 24, 2026, 22:09 long, audio available.